Bayesian Capital Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-36,090
| Closed | -$233K | – | 664 |
|
|
2023
Q2 | $233K | Buy |
36,090
+17,200
| +91% | +$111K | 0.03% | 601 |
|
|
2023
Q1 | $142K | Sell |
18,890
-16,500
| -47% | -$124K | 0.02% | 648 |
|
|
2022
Q4 | $359K | Buy |
35,390
+500
| +1% | +$5.07K | 0.05% | 438 |
|
|
2022
Q3 | $345K | Buy |
34,890
+8,100
| +30% | +$80.1K | 0.07% | 371 |
|
|
2022
Q2 | $285K | Sell |
26,790
-910
| -3% | -$9.68K | 0.05% | 499 |
|
|
2022
Q1 | $270K | Buy |
+27,700
| New | +$270K | 0.04% | 553 |
|
|
2021
Q3 | – | Sell |
-22,900
| Closed | -$504K | – | 364 |
|
|
2021
Q2 | $504K | Buy |
+22,900
| New | +$504K | 0.13% | 189 |
|